User menu

Brain iron metabolism and its perturbation in neurological diseases.

Bibliographic reference Crichton, Robert ; Dexter, David T ; Ward, Roberta J.. Brain iron metabolism and its perturbation in neurological diseases.. In: Journal of Neural Transmission. General Section, Vol. 118, no. 3, p. 301-314 (2011)
Permanent URL http://hdl.handle.net/2078.1/33224
  1. Abbott N. Joan, Patabendige Adjanie A.K., Dolman Diana E.M., Yusof Siti R., Begley David J., Structure and function of the blood–brain barrier, 10.1016/j.nbd.2009.07.030
  2. Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of ageing: Alzheimer’s Disease, Parkinson’s Disease and Atherosclerosis. J Alzheimers Dis 16:879–895
  3. Arawaka S., Saito Y., Murayama S., Mori H., Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for  -synuclein, 10.1212/wnl.51.3.887
  4. Babitt Jodie L, Huang Franklin W, Wrighting Diedra M, Xia Yin, Sidis Yisrael, Samad Tarek A, Campagna Jason A, Chung Raymond T, Schneyer Alan L, Woolf Clifford J, Andrews Nancy C, Lin Herbert Y, Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression, 10.1038/ng1777
  5. Beal M.Flint, Oxidatively modified proteins in aging and disease1,2 1Guest Editor: Earl Stadtman 2This article is part of a series of reviews on “Oxidatively Modified Proteins in Aging and Disease.” The full list of papers may be found on the homepage of the journal., 10.1016/s0891-5849(02)00780-3
  6. Beard JL (2008) Why iron deficiency is important in infant development. J Nutr 138:2534–2536
  7. Beard John L., Wiesinger Jason A., Connor James R., Pre- and Postweaning Iron Deficiency Alters Myelination in Sprague-Dawley Rats, 10.1159/000073507
  8. Beard J, Erikson KM, Jones BC (2003b) Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J Nutr 133:1174–1179
  9. Berlett Barbara S., Stadtman Earl R., Protein Oxidation in Aging, Disease, and Oxidative Stress, 10.1074/jbc.272.33.20313
  10. Bradbury MWB (1997) Transport of iron in the blood–brain–cerebrospinal fluid system. J Neurochem 67:443–454
  11. Burdette S. C., Lippard S. J., Meeting of the minds: Metalloneurochemistry, 10.1073/pnas.0637711100
  12. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., Connor J.R., Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat, 10.1002/jnr.1256
  13. Burhans Maggie S., Dailey Catherine, Beard Zachary, Wiesinger Jason, Murray-Kolb Laura, Jones Byron C., Beard John L., Iron deficiency: Differential effects on monoamine transporters, 10.1080/10284150500047070
  14. Bush AL, Tanzi RE (2002) The galvanization of beta-amyloid in Alzheimer’s disease. Proc Natl Acad Sci USA 99:97317–97319
  15. Castellani R. J., Siedlak S. L., Perry G., Smith M. A., Sequestration of iron by Lewy bodies in Parkinson's disease, 10.1007/s004010050001
  16. Catalá Angel, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, 10.1016/j.chemphyslip.2008.09.004
  17. Cho HH, Cahill CM, Vanderburg CR et al (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem. doi: 10.1074/jbc.M110.149161
  18. Connor J. R., Snyder B. S., Beard J. L., Fine R. E., Mufson E. J., Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease, 10.1002/jnr.490310214
  19. Crichton RR (2008) Biological chemistry: an introduction. Elsevier, Amsterdam, p 369
  20. Crichton RR (2009) Inorganic biochemistry of iron metabolism from molecular mechanisms to clinical consequences, 3rd edn. John Wiley and Sons, Chichester, pp 461
  21. Crichton RR, Ward RJ (2006) Metal-based neurodegeneration. From molecular mechanisms to therapeutic strategies John Wiley and Sons, pp 227
  22. Crichton Robert R., Dexter D.T., Ward Roberta J., Metal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategies, 10.1016/j.ccr.2007.10.019
  23. Dalle-Donne Isabella, Giustarini Daniela, Colombo Roberto, Rossi Ranieri, Milzani Aldo, Protein carbonylation in human diseases, 10.1016/s1471-4914(03)00031-5
  24. Dallman P.R., Beutler E., Finch C.A., EFFECTS OF IRON DEFICIENCY EXCLUSIVE OF ANAEMIA, 10.1111/j.1365-2141.1978.tb03655.x
  25. Dallman PR, Siimes MA, Stekel A (1980) Iron deficiency in infancy and childhood. Am J Clin Nutr 33:86–118
  26. De Domenico Ivana, Ward Diane McVey, di Patti Maria Carmela Bonaccorsi, Jeong Suh Young, David Samuel, Musci Giovanni, Kaplan Jerry, Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin, 10.1038/sj.emboj.7601735
  27. Fisher J., Devraj K., Ingram J., Slagle-Webb B., Madhankumar A. B., Liu X., Klinger M., Simpson I. A., Connor J. R., Ferritin: a novel mechanism for delivery of iron to the brain and other organs, 10.1152/ajpcell.00599.2006
  28. Goedert Michel, Alpha-synuclein and neurodegenerative diseases, 10.1038/35081564
  29. Golts Natalie, Snyder Heather, Frasier Mark, Theisler Catherine, Choi Peter, Wolozin Benjamin, Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein, 10.1074/jbc.m107866200
  30. GÖTZ MARIO E., DOUBLE KAY, GERLACH MANFRED, YOUDIM MOUSSA B. H., RIEDERERE PETER, The Relevance of Iron in the Pathogenesis of Parkinson's Disease, 10.1196/annals.1306.017
  31. Grimsrud Paul A., Xie Hongwei, Griffin Timothy J., Bernlohr David A., Oxidative Stress and Covalent Modification of Protein with Bioactive Aldehydes, 10.1074/jbc.r700019200
  32. Hashimoto Makoto, Hsu Leigh J., Xia Yu, Takeda Ayako, Sisk Abbyann, Sundsmo Mary, Masliah Eliezer, Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro : , 10.1097/00001756-199903170-00011
  33. Hentze M. W., Kuhn L. C., Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress., 10.1073/pnas.93.16.8175
  34. HONDA KAZUHIRO, CASADESUS GEMMA, PETERSEN ROBERT B., PERRY GEORGE, SMITH MARK A., Oxidative Stress and Redox-Active Iron in Alzheimer's Disease, 10.1196/annals.1306.015
  35. Honda Kazuhiro, Smith Mark A., Zhu Xiongwei, Baus Diane, Merrick William C., Tartakoff Alan M., Hattier Thomas, Harris Peggy L., Siedlak Sandra L., Fujioka Hisashi, Liu Quan, Moreira Paula I., Miller Frank P., Nunomura Akihiko, Shimohama Shun, Perry George, Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron, 10.1074/jbc.m500526200
  36. Hwang Eun Mi, Kim Su-Kyoung, Sohn Ji-Hoon, Lee Ji Yeon, Kim Youngho, Kim Yong Shik, Mook-Jung Inhee, Furin is an endogenous regulator of α-secretase associated APP processing, 10.1016/j.bbrc.2006.08.077
  37. Jeong Suh Young, David Samuel, Glycosylphosphatidylinositol-anchored Ceruloplasmin Is Required for Iron Efflux from Cells in the Central Nervous System, 10.1074/jbc.m301988200
  38. Lozoff Betsy, Beard John, Connor James, Felt Barbara, Georgieff Michael, Schallert Timothy, Long-Lasting Neural and Behavioral Effects of Iron Deficiency in Infancy, 10.1301/nr.2006.may.s34-s43
  39. McMahon Stephanie, Grondin Francine, McDonald Patrick P., Richard Darren E., Dubois Claire M., Hypoxia-enhanced Expression of the Proprotein Convertase Furin Is Mediated by Hypoxia-inducible Factor-1 : IMPACT ON THE BIOACTIVATION OF PROPROTEINS, 10.1074/jbc.m413248200
  40. Moos Torben, Morgan Evan H., A Morphological Study of the Developmentally Regulated Transport of Iron into the Brain, 10.1159/000065702
  41. Moos Torben, Morgan Evan H., The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain : DMT1 in Belgrade rat brain, 10.1046/j.1471-4159.2003.02142.x
  42. Moos Torben, Rosengren Nielsen Thomas, Ferroportin in the Postnatal Rat Brain: Implications for Axonal Transport and Neuronal Export of Iron, 10.1016/j.spen.2006.08.003
  43. Moos Torben, Oates Phillip S., Morgan Evan H., Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency, 10.1002/(sici)1096-9861(19980831)398:3<420::aid-cne8>3.0.co;2-1
  44. Moos Torben, Skjoerringe Tina, Gosk Sara, Morgan Evan H., Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1 : Iron transport at the blood-brain barrier, 10.1111/j.1471-4159.2006.04023.x
  45. Moos Torben, Nielsen Thomas Rosengren, Skjørringe Tina, Morgan Evan H., Iron trafficking inside the brain, 10.1111/j.1471-4159.2007.04976.x
  46. Morgan E, Iron exchange between transferrin molecules mediated by phosphate compounds and other cell metabolites, 10.1016/0304-4165(77)90239-2
  47. Morgan E.H., Studies on the mechanism of iron release from transferrin, 10.1016/0005-2795(79)90144-2
  48. Mueller Sebastian, Iron regulatory protein 1 as a sensor of reactive oxygen species, 10.1002/biof.5520240121
  49. Münch G., Lüth H.J., Wong A., Arendt Th., Hirsch E., Ravid R., Riederer P., Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?, 10.1016/s0891-0618(00)00096-x
  50. Oakley A. E., Collingwood J. F., Dobson J., Love G., Perrott H. R., Edwardson J. A., Elstner M., Morris C. M., Individual dopaminergic neurons show raised iron levels in Parkinson disease, 10.1212/01.wnl.0000262033.01945.9a
  51. Oe Tomoyuki, Arora Jasbir S., Lee Seon Hwa, Blair Ian A., A Novel Lipid Hydroperoxide-derived Cyclic Covalent Modification to Histone H4, 10.1074/jbc.m308167200
  52. Ohgami R. S., The Steap proteins are metalloreductases, 10.1182/blood-2006-02-003681
  53. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., Connor J.R., Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models, 10.1002/jnr.20207
  54. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20:6048–6054
  55. Rao Raghavendra, Georgieff Michael K., Iron in fetal and neonatal nutrition, 10.1016/j.siny.2006.10.007
  56. Rao R, Tkac I, Townsend EL, Gruetter R, Georgieff MK (2003) Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. J Nutr 133:3215–3221
  57. Rao Raghavendra, Tkac Ivan, Townsend Elise L, Ennis Kathleen, Gruetter Rolf, Georgieff Michael K, Perinatal Iron Deficiency Predisposes the Developing Rat Hippocampus to Greater Injury from Mild to Moderate Hypoxia—Ischemia, 10.1038/sj.jcbfm.9600394
  58. Rogers Jack T., Randall Jeffrey D., Cahill Catherine M., Eder Paul S., Huang Xudong, Gunshin Hiromi, Leiter Lorene, McPhee Jay, Sarang Satinder S., Utsuki Tada, Greig Nigel H., Lahiri Debomoy K., Tanzi Rudolph E., Bush Ashley I., Giordano Tony, Gullans Steve R., An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript, 10.1074/jbc.m207435200
  59. Rouault Tracey A., Cooperman Sharon, Brain Iron Metabolism, 10.1016/j.spen.2006.08.002
  60. Sangchot P., Sharma S., Chetsawang B., Porter J., Govitrapong P., Ebadi M., Deferoxamine Attenuates Iron-Induced Oxidative Stress and Prevents Mitochondrial Aggregation and α-Synuclein Translocation in SK-N-SH Cells in Culture, 10.1159/000065700
  61. Sayre Lawrence M., Lin De, Yuan Quan, Zhu Xiaochun, Tang Xiaoxia, Protein Adducts Generated from Products of Lipid Oxidation: Focus on HNE and ONE, 10.1080/03602530600959508
  62. Schapira Anthony H. V., Olanow C. Warren, Neuroprotection in Parkinson Disease : Mysteries, Myths, and Misconceptions, 10.1001/jama.291.3.358
  63. Schneider Claus, Porter Ned A., Brash Alan R., Routes to 4-Hydroxynonenal: Fundamental Issues in the Mechanisms of Lipid Peroxidation, 10.1074/jbc.r800001200
  64. Seidah N.G., Chrétien M., Day R., The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functions, 10.1016/0300-9084(94)90147-3
  65. Silvestri Laura, Camaschella Clara, A potential pathogenetic role of iron in Alzheimer's disease, 10.1111/j.1582-4934.2008.00356.x
  66. Silvestri L., Pagani A., Camaschella C., Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis, 10.1182/blood-2007-07-100677
  67. Sipe Jack C., Lee Pauline, Beutler Ernest, Brain Iron Metabolism and Neurodegenerative Disorders, 10.1159/000065701
  68. Smith M. A., Harris P. L. R., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, 10.1073/pnas.94.18.9866
  69. Stadtman Earl R., Protein oxidation and aging, 10.1080/10715760600918142
  70. Tachida Yuriko, Nakagawa Kazuhiro, Saito Takashi, Saido Takaomi C., Honda Takashi, Saito Yuko, Murayama Shigeo, Endo Tamao, Sakaguchi Gaku, Kato Akira, Kitazume Shinobu, Hashimoto Yasuhiro, Interleukin-1β up-regulates TACE to enhance α-cleavage of APP in neurons: resulting decrease in Aβ production, 10.1111/j.1471-4159.2007.05127.x
  71. Takanashi Masashi, Mochizuki Hideki, Yokomizo Kazuko, Hattori Nobutaka, Mori Hideo, Yamamura Yasuhiro, Mizuno Yoshikuni, Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP), 10.1016/s1353-8020(00)00050-x
  72. Ward KL, Tkac I, Jing Y, Felt B, Beard J, Connor J, Schallert T, Georgieff MK, Rao R (2007) Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats. J Nutr 137:1043–1049
  73. Woods HF, Youdim MB, Boullin D, Callender S (1976) Monoamine metabolism and platelet function in iron-deficiency anaemia. Ciba Found Symp 51:227–248
  74. Wu Laura Jui-chen, Leenders A.G.Miriam, Cooperman Sharon, Meyron-Holtz Esther, Smith Sophia, Land William, Tsai Robert Y.L., Berger Urs V., Sheng Zu-Hang, Rouault Tracey A., Expression of the iron transporter ferroportin in synaptic vesicles and the blood–brain barrier, 10.1016/j.brainres.2003.10.066
  75. Zarkovic Neven, 4-Hydroxynonenal as a bioactive marker of pathophysiological processes, 10.1016/s0098-2997(03)00023-2
  76. Zarkovic Kamelija, 4-Hydroxynonenal and neurodegenerative diseases, 10.1016/s0098-2997(03)00024-4
  77. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Giaveri G., Arosio P., Santambrogio P., Fariello R. G., Karatekin E., Kleinman M. H., Turro N., Hornykiewicz O., Zucca F. A., The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging, 10.1073/pnas.0403495101
  78. Zecca Luigi, Youdim Moussa B. H., Riederer Peter, Connor James R., Crichton Robert R., Iron, brain ageing and neurodegenerative disorders, 10.1038/nrn1537
  79. Zhang Wei-Han, Liu Jiyun, Xu Guozhang, Yuan Quan, Sayre Lawrence M., Model Studies on Protein Side Chain Modification by 4-Oxo-2-nonenal†, 10.1021/tx020105a
  80. Zimmer Michael, Ebert Benjamin L., Neil Christopher, Brenner Keith, Papaioannou Ioannis, Melas Antonia, Tolliday Nicola, Lamb Justin, Pantopoulos Kostas, Golub Todd, Iliopoulos Othon, Small-Molecule Inhibitors of HIF-2a Translation Link Its 5′UTR Iron-Responsive Element to Oxygen Sensing, 10.1016/j.molcel.2008.12.004